Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Reshaping human antibodies for therapy.

Riechmann L, Clark M, Waldmann H, Winter G.

Nature. 1988 Mar 24;332(6162):323-7.

PMID:
3127726
[PubMed - indexed for MEDLINE]
2.

Tailor-made monoclonal antibodies.

DePinho RA, Feldman LB, Scharff MD.

Ann Intern Med. 1986 Feb;104(2):225-33. Review.

PMID:
3080934
[PubMed - indexed for MEDLINE]
3.

Genetically engineered antibody molecules.

Morrison SL, Oi VT.

Adv Immunol. 1989;44:65-92. Review. No abstract available.

PMID:
2646862
[PubMed - indexed for MEDLINE]
4.

Humanisation of monoclonal antibodies for therapy.

Gorman SD, Clark MR.

Semin Immunol. 1990 Nov;2(6):457-66. Review.

PMID:
2104282
[PubMed - indexed for MEDLINE]
5.

Engineering monoclonal antibodies to determine the structural requirements for complement activation and complement mediated lysis.

Sandlie I, Michaelsen TE.

Mol Immunol. 1991 Dec;28(12):1361-8. Review. No abstract available.

PMID:
1749385
[PubMed - indexed for MEDLINE]
6.

Human immunoglobulin allotypes: possible implications for immunogenicity.

Jefferis R, Lefranc MP.

MAbs. 2009 Jul-Aug;1(4):332-8. Review. No abstract available.

PMID:
20073133
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk